How Can You Mitigate The Risks Of Single-Use Bags?

The loss of product as a result of bag failure isn’t just an annoyance; it’s an expense, and a costly one at that. However, Chuck Hart, director of manufacturing at Prolong Pharmaceuticals, says with proper fitting and handling, these concerns can be mitigated.

More From The Editor...


More BioProcess Insights


  • Could AbbVie Hurt Itself With Biosimilar Labeling Demands?
    Could AbbVie Hurt Itself With Biosimilar Labeling Demands?

    In May, the FDA changed its stance on several key points of its draft version of the “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product.” In accordance with these changes, any biosimilar licensed under the PHS Act § 351 (k) no longer needs to contain a statement on its label indicating that it is a biosimilar.

  • Do Biosimilars Fit Into The Innovation Paradigm?
    Do Biosimilars Fit Into The Innovation Paradigm?

    As an industry, pharma is inundated with the term “innovation.” Patent laws and data exclusivity negotiations like the stalled Trans-Pacific Partnership (TPP) are centered around protecting innovation. Bayer recently established a team dedicated solely to pursuing innovation — though board member Kemal Malik was quick to tell Life Science Leader magazine that most people in the industry “have a tough time explaining [innovation].”

  • Could Birth Of “Big Generic” Be Foreshadowing “Big Biosimilar?”
    Could Birth Of “Big Generic” Be Foreshadowing “Big Biosimilar?”

    The past few weeks, the generics market has seen several players jump ship and one company grow significantly — and to some, alarmingly — larger.

  • TPP Negotiations Stall, Hold Back Biosimilars Market
    TPP Negotiations Stall, Hold Back Biosimilars Market

    As if the biosimilar naming debate between brand-name pharmaceutical companies and generic drugmakers wasn’t enough, these two sides continue to challenge each other — this time, over biologics data exclusivity in the ongoing Trans-Pacific Partnership (TPP) negotiations.

  • New Teva, AstraZeneca Deals To Bolster Emerging Biosimilars Market
    New Teva, AstraZeneca Deals To Bolster Emerging Biosimilars Market

    After this week, it looks like there will be a few big players advancing in the biosimilar market. For those concerned about what a Teva-Mylan acquisition deal would do to the generics industry, recent action on behalf of Teva finally put those fears to bed.

More From Bioprocess Contributing Editors


  • Global Cold Chain Logistics
    Global Cold Chain Logistics

    As cold chain shipments excursions face increased scrutiny from regulators around the world, it is more important than ever before to get it right the first time.

  • 405 Touch Microplate Washer
    405 Touch Microplate Washer

    The 405 Touch Microplate Washer features the new patented* Verify™ Technology, which runs an automated QC check for manifold tube blockage, and visually reports any failed wells.

  • Solutions For On-time, Deficient-Free Delivery Of Medical Supplies, Medicines And Other Products
    Solutions For On-time, Deficient-Free Delivery Of Medical Supplies, Medicines And Other Products

    For the person with diabetes in need of insulin, the heart patient awaiting a monitor or the individual expecting critical lab results, a delay of even one day isn't acceptable. Timely delivery of medical supplies or medication could mean the difference between recovery and relapse.

  • Chromatography Media
    Chromatography Media

    GE Healthcare's range of chromatography media and systems cover several different types of liquid chromatography at all scales of purification from research to process-scale.

  • PureTemp - Phase Change Materials (PCMs)

    The industry’s only USDA Bio Preferred phase change material. ThermoPhase powered by PureTemp bio-based PCMs are non-hazardous, 100 percent renewable and environmentally-friendly. Even after thousands of thermal cycles, tests show PureTemp experiences no thermal degradation.

More Products


BioProcess Online Videos


  • Grace

    Grace is a global provider of process manufacturing solutions supporting pharmaceutical and biotech industries. Our range of solutions includes peptide building blocks for API synthesis, chromatographic media and packing equipment for process purification, and multifunctional silica excipients for pharmaceutical formulation.

  • ILC Dover
    ILC Dover

    As the pioneer of Flexible Containment solutions for the pharmaceutical industry we’ve created a number of products to address the safe handling of highly potent powders. These products are customer driven and address a wide range of processing needs. Coupled together these products permit complete process train containment.

  • Finesse Solutions, LLC
    Finesse Solutions, LLC

    California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer.

More Suppliers....





Bioprocess Online is the leading source of technical information and thought leadership for the biotherapeutic community. If you are a bioprocess engineer, scientist, bioprocessing manager, biotechnology producer, consultant, QA/QC, project manager, director, purchaser, marketer, or if you are involved in biopharm supply chain or facilities management, you now have access to a comprehensive Web community delivering the latest updates on the business and scientific information you need to succeed in your industry. From upstream to downstream processing through bioanalysis and biomanufacturing, our goal is to provide readers with the most up-to-date information about the issues, challenges, and news they care about most.

BioProcess Online is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market. Connect, Collaborate, Contribute.

Please take a moment to join our community and discover the benefits of your free membership.


Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.


Attendees call it “an A+ show,” and Pharma EXPO 2015 will deliver solutions for the entire pharma supply chain from 200 top-tier suppliers, networking opportunities with 5,000 peers and a world-class conference program from International Society for Pharmaceutical Engineering (ISPE). 


Learn More


Using Social Media for Patient Recruitment in Clinical Trials

September 3, 2015
1pm-2:30pm EDT, Online Training

Monitoring Electronic Health Records (EHRs): Frequently Asked Questions

September 9, 2015
1pm-2:30pm EDT, Online Training

Laboratory Data Integrity: Current Expectations for OOS Result Investigations

September 16, 2015
1pm-2:30pm EDT, Online Training
More Upcoming Courses


  • World Courier Biomedical Seminar 2015
    World Courier Biomedical Seminar 2015

    The World Courier Biomedical Seminar is the global conference where pharmaceutical, research and regulatory leaders receive insight on the dynamic industry — and the impact on global specialty transport. You’ll collaborate with industry thought leaders to surface new and innovative ways to solve business challenges.

  • Advancing Research In Skin Biology with Metabolomics
    Advancing Research In Skin Biology with Metabolomics

    This 30-minute webinar demonstrates how metabolomics can be a powerful tool in dermatological and skincare research.

  • Leveraging Metabolite Biomarkers For Clinical Trials
    Leveraging Metabolite Biomarkers For Clinical Trials

    This 30-minute webinar will introduce a robust, highly sensitive biomarker development program that leverages a revolutionary metabolomics discovery platform to improve the range of analytes that can be measured routinely and reliably.

More Life Science Webinars